Primary content

Related to 'Prostate cancer'

During 1982-2013, AIHW estimates were consistently higher than our competing mortality-adjusted estimates of lifetime risks of diagnosis and death.

What is prostate cancer? Find the latest prostate cancer data including incidence, mortality and survival in NSW.

Few long-term prostate cancer survivors use diet or exercise to help with their prostate cancer, despite evidence supporting the use of diet and exercise to improve quality of life and cancer-related outcomes.

Prostate cancer incidence and mortality rates have declined or stabilized during recent years in many countries, with these decreases being more pronounced in high-income countries.

Prostate cancer is the most common cancer in NSW men, but statewide collaboration is leading to better outcomes.

RD-staging provided the greatest stage data completeness and alignment to AJCC-TNM for prostate cancers, followed by breast, then melanoma and lung cancers.

The annual number of prostate cancer cases diagnosed in Australia increased from 3,606 in 1982 to 20,065 in 2012. The number of incident prostate cancer cases is projected to rise to 25,283 in 2022.

The estimated rate of overdiagnosis of prostate cancer was in agreement with estimates using other methods. The excess lifetime risk of prostate cancer in 2012 (adjusted for changing competing mortality) was 8.2%, corresponding to 41% of prostate cancers being overdiagnosed.

Tony Maxwell is helping to change the lives of men with prostate cancer, all while living with his own disease.